CYTONUS THERAPEUTICS, INC. SBIR Phase I Award, September 2021
A SBIR Phase I contract was awarded to Cytonus Therapeutics in September, 2021 for $297,553.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like CYTONUS THERAPEUTICS, INC. SBIR Phase I Award, September 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.